Local Institution - 0027

München 81675

1 studies enrolling now · 1 studies all time

What they study most

Advanced Renal Cell Carcinoma (RCC)

Studies at this site

• A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) — Recruiting now